PCM
RPRX icon

Portolan Capital Management’s Royalty Pharma RPRX Stock Holding History

Portolan Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-352,257
Closed -$11M – 137
2025
Q1 		$11M Buy
352,257
+8,072
+2% +$256K 0.83% 43
2024
Q4 		$8.78M Buy
344,185
+173,721
+102% +$4.61M 0.59% 62
2024
Q3 		$4.82M Buy
+170,464
New +$4.72M 0.35% 88
2024
Q2 		– Sell
-288,378
Closed -$8.76M – 131
2024
Q1 		$8.76M Buy
288,378
+138,551
+92% +$4.08M 0.67% 54
2023
Q4 		$4.21M Buy
149,827
+71,475
+91% +$1.96M 0.37% 83
2023
Q3 		$2.13M Sell
78,352
-60,139
-43% -$1.79M 0.2% 107
2023
Q2 		$4.26M Sell
138,491
-73,962
-35% -$2.51M 0.38% 77
2023
Q1 		$7.65M Buy
+212,453
New +$7.88M 0.73% 47

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return